STRATEGIC ARRANGEMENTS (Details) - USD ($) |
12 Months Ended | ||||
|---|---|---|---|---|---|
Aug. 02, 2017 |
Dec. 01, 2007 |
Dec. 31, 2017 |
Dec. 31, 2016 |
Dec. 31, 2015 |
|
| Research and Development Arrangement, Contract to Perform for Others [Line Items] | |||||
| Minimum annual royalty payment | $ 500,000 | ||||
| Royalty Agreement Terms | CASE | |||||
| Research and Development Arrangement, Contract to Perform for Others [Line Items] | |||||
| Royalty agreement period | 10 years | 10 years | |||
| Minimum annual royalty payment | $ 10,000 | ||||
| Royalty agreement percentage | 3.00% | ||||
| Milestone payments for FDA approval to sell our products within the United States | $ 5,000 | ||||
| Milestone payment for general product launch | 10,000 | ||||
| Royalty expense | 148,000 | $ 119,000 | $ 120,000 | ||
| Royalty payable | $ 37,000 | $ 34,000 | |||